Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 557-565

  Mutlu, Oguz ^a   Ulak, Güner ^a   Celikyurt, Ipek Komsuoglu ^a   Akar, Füruzan Yildiz ^a   Erden, Faruk ^a   Tanyeri, Pelin ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Atypical antipsychotics; Cognition; Mice; MK 801; Novel object recognition test; Open field test

Indexed keywords

CLOZAPINE; DIZOCILPINE; OLANZAPINE; SERTINDOLE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; VISUAL MEMORY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; IMIDAZOLES; INDOLES; LEARNING; MALE; MEMORY DISORDERS; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; RECOGNITION (PSYCHOLOGY); VISUAL PERCEPTION;

ANIMALIA; MUS;

EID: 79959564385     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.011     Document Type: Article

References (51)

1. Z. Abdul-Monim, G.P. Reynolds, and J.C. Neill The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat J Psychopharmacol 17 2003 57 65 (Pubitemid 36373141)
2. H.A. Al-Amin, and S.B. Schwarzkopf Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia Biol Psychiatry 40 1996 744 754 (Pubitemid 26353968)
3. J.M. Alvir, J.A. Lieberman, A.Z. Safferman, J.L. Schwimmer, and J.A. Schaaf Clozapine-induced agranulocytosis. Incidence and risk factors in the United States N Engl J Med 329 3 1993 162 167 (Pubitemid 23195736)
4. J. Arnt, and T. Skarsfeldt Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 1998 63 101 (Pubitemid 28026679)
5. M.E. Bardgett, R. Boeckman, D. Krochmal, H. Fernando, R. Ahrens, and J.G. Csernansky NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice Brain Res Bull 60 2003 131 142 (Pubitemid 36506460)
6. C. Belzung Measuring exploratory behavior W.E. Crusio, R.T. Gerlai, Handbook of Molecular Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral and Neural Sciences) 1999 Elsevier Amsterdam 739 749
7. C. Bischoff, and P.I. Tiedtke Competitive and noncompetitive NMDA receptor antagonists in spatial learning tasks Eur J Pharmacol 213 1992 269 273
8. F.P. Bymaster, D.O. Calligaro, J.F. Falcone, R.D. Marsh, N.A. Moore, and N.C. Tye Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 1996 87 96 (Pubitemid 26053226)
9. M.E. Calkins, R.C. Gur, J.D. Ragland, and R.E. Gur Face recognition memory deficits and visual object memory performance in patients with schizophrenia and their relatives Am J Psychiatry 162 2005 1963 1966 (Pubitemid 41428629)
10. M.L. Carlsson Are the disparate pharmacological profiles of competitive and uncompetitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? J Neural Transm 94 1993 1 10 (Pubitemid 23330057)
11. J. Cartmell, J.A. Monn, and D.D. Schoepp Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine Psychopharmacology (Berl) 148 2000 423 429 (Pubitemid 30169761)
12. C. Castellano, V. Cestari, and A. Ciamei NMDA receptors and learning and memory processes Curr Drug Targets 2 2001 273 283 (Pubitemid 32821470)
13. M.N. De Lima, D.C. Laranja, E. Bromberg, R. Roesler, and N.A. Schroder Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats Behav Brain Res 156 2005 139 143 (Pubitemid 39330444)
14. M. Didriksen Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm Eur J Pharmacol 281 1995 241 250
15. M. Didriksen, and F. Sams-Dodd Effects of haloperidol, clozapine, and sertindole on cognitive function in rats after chronic treatment Soc Neurosci Abstr 23 1997 1932
16. M. Didriksen, M. Kreilgaard, and J. Arnt Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment Eur J Pharmacol 542 2006 108 115 (Pubitemid 44066366)
17. M. Didriksen, T. Skarsfeldt, and J. Arnt Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics Psychopharmacology 193 2007 225 233 (Pubitemid 47025022)
18. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data Behav Brain Res 31 1988 47 59
19. B. Gallhofer, S. Lis, A. Meyer-Lindenberg, and S. Krieger Cognitive dysfunction in schizophrenia: a new set of tools for the assessment of cognition and drug effects Acta Psychiatr Scand 99 395 1999 118 128 (Pubitemid 29151873)
20. S.D. Gleason, and H.E. Shannon Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice Psychopharmacology 129 1997 79 84 (Pubitemid 27037454)
21. C.S. Hall Emotional behavior in the rat: I. Defecation and urination as measures of individual differences in emotionality J Comp Psychol 18 1934 385 403
22. P.D. Harvey, and R.S. Keefe Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment Am J Psychiatry 158 2001 176 184 (Pubitemid 32116511)
23. K. Hashimoto, Y. Fujita, E. Shimizu, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent sub-chronic administration of clozapine, but not haloperidol Eur J Pharmacol 519 2005 114 117 (Pubitemid 43181173)
24. W. Hirst, T. Stean, D. Rogers, D. Sunter, P. Pugh, and S. Moss SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models Eur J Pharmacol 553 2006 109 119 (Pubitemid 44779592)
25. J. Ichikawa, J. Dai, I.A. O'Laughlin, W.L. Fowler, and H.Y. Meltzer Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum Neuropsychopharmacology 26 2002 325 339 (Pubitemid 34159210)
26. K. Ishida-Tokuda, Y. Ohno, H. Sakamoto, T. Ishibashi, J. Wakabayashi, and R. Tojima Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats Jpn J Pharmacol 72 1996 119 126 (Pubitemid 26390722)
27. D.C. Javitt, and R.S. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
28. W. Koek, J.H. Woods, and G.D. Winger MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys J Pharmacol Exp Ther 245 1988 969 974
29. J.E. Leysen Receptor profile of antipsychotics B.A. Ellenbroek, A.R. Cools, Atypical antipsychotics. Milestones in drug therapy 2000 Basel Birkhäuser Verlag 57 81
30. C.E. Marx, L.J. Shampine, G.E. Duncan, M.J. VanDoren, A.C. Grobin, and M.W. Massing Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? Pharmacol Biochem Behav 84 2006 598 608 (Pubitemid 350061236)
31. C.E. Marx, L.J. Shampine, R.T. Khisti, W.T. Trost, D.W. Bradford, and A.C. Grobin Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions Pharmacol Biochem Behav 84 2006 609 617 (Pubitemid 350081089)
32. O. Mutlu, G. Ulak, I. Komsuoglu, F.Y. Akar, and F. Erden Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801 treated mice Pharmacol Biochem Behav 98 2011 398 404
33. N. Okamura, K. Yanai, M. Higuchi, J. Sakai, R. Iwata, and T. Ido Functional neuroimaging of cognition impaired by a classical antihistamine, D-chlorpheniramine Br J Pharmacol 129 2000 115 123 (Pubitemid 30072677)
34. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur J Pharmacol 463 2003 3 33 (Pubitemid 36205070)
35. S.E. Purdon, A. Malla, A. Labelle, and W. Lit Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol J Psychiatry Neurosci 26 2001 137 149 (Pubitemid 32373127)
36. G. Riedel, B. Platt, and J. Micheau Glutamate receptor function in learning and memory Behav Brain Res 140 2003 1 47 (Pubitemid 36313239)
37. P.J. Riekkinen, J. Sirvio, M. Aaltonen, and P. Riekkinen Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning Pharmacol Biochem Behav 37 1990 405 410
38. A. Schotte, P.F. Janssen, W. Gommeren, W.H. Luyten, G.P. Van, and A.S. Lesage Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology (Berl) 124 1996 57 73 (Pubitemid 26112775)
39. A.C. Sharma, and S.K. Kulkarni MK-801 produces antianxiety effect in elevated plus-maze in mice Drug Dev Res 22 1991 251 258
40. S. Shirazi-Southall, D.E. Rodriguez, and G.G. Nomikos Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat Neuropsychopharmacology 26 2002 583 594 (Pubitemid 34260977)
41. T. Skarsfeldt Differential effect of antipsychotics on place navigation of rats in the Morris water maze Psychopharmacology 124 1996 126 133
42. M. Tashiro, H. Mochizuki, K. Iwabuchi, Y. Sakurada, M. Itoh, and T. Watanabe Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain Life Sci 72 2002 409 414 (Pubitemid 35452554)
43. W. Timmerman, P.G. Tepper, B.G. Bohus, and A.S. Horn The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437 Eur J Pharmacol 181 1990 253 260 (Pubitemid 20185898)
44. M.D. Tricklebank, L. Singh, R.J. Oles, C. Preston, and S.D. Iversen The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor Eur J Pharmacol 167 1989 127 135 (Pubitemid 19213713)
45. R.N. Walsh, and R.A. Cummins The open field test: a critical review Psychol Bull 83 1976 481 504
46. D.M. Weiner, H.Y. Meltzer, I. Veinbergs, E.M. Donohue, T.A. Spalding, and T.T. Smith The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology (Berl) 177 2004 207 216 (Pubitemid 40109932)
47. M.C. Wolff, and J.D. Leander Comparison of the effects of antipsychotics on a delayed radial maze task in the rat Psychopharmacology (Berl) 168 2003 410 416 (Pubitemid 36994024)
48. E.H. Wong, and M. Nielsen The N-methyl-D-aspartate receptor channel complex and the sigma site have different target sizes Eur J Pharmacol 172 1989 493 496 (Pubitemid 20007447)
49. Z. Xie, and R.L. Commissaris Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801 Pharmacol Biochem Behav 43 2 1992 471 477
50. L. Xi-Ming, K.W. Perry, D.T. Wong, and F.P. Bymaster Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum Psychopharmacology 136 1998 153 161 (Pubitemid 28137955)
51. W. Zhang, and F.P. Bymaster The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors Psychopharmacology (Berl) 141 1999 267 278 (Pubitemid 29196076)